507 related articles for article (PubMed ID: 31515562)
1. Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis.
Bjornevik K; Munger KL; Cortese M; Barro C; Healy BC; Niebuhr DW; Scher AI; Kuhle J; Ascherio A
JAMA Neurol; 2020 Jan; 77(1):58-64. PubMed ID: 31515562
[TBL] [Abstract][Full Text] [Related]
2. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
Disanto G; Barro C; Benkert P; Naegelin Y; Schädelin S; Giardiello A; Zecca C; Blennow K; Zetterberg H; Leppert D; Kappos L; Gobbi C; Kuhle J;
Ann Neurol; 2017 Jun; 81(6):857-870. PubMed ID: 28512753
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study.
Bittner S; Steffen F; Uphaus T; Muthuraman M; Fleischer V; Salmen A; Luessi F; Berthele A; Klotz L; Meuth SG; Bayas A; Paul F; Hartung HP; Linker R; Heesen C; Stangel M; Wildemann B; Then Bergh F; Tackenberg B; Kuempfel T; Weber F; Zettl UK; Ziemann U; Tumani H; Groppa S; Mühlau M; Lukas C; Hemmer B; Wiendl H; Gold R; Zipp F;
EBioMedicine; 2020 Jun; 56():102807. PubMed ID: 32460167
[TBL] [Abstract][Full Text] [Related]
4. Serum neurofilament light chain and glial fibrillary acidic protein in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders and multiple sclerosis: A cohort study.
Liu C; Lu Y; Wang J; Chang Y; Wang Y; Chen C; Liu Z; Kermode AG; Zhang Y; Qiu W
J Neurochem; 2021 Dec; 159(5):913-922. PubMed ID: 34278578
[TBL] [Abstract][Full Text] [Related]
5. Serum neurofilament light chain in pediatric MS and other acquired demyelinating syndromes.
Wong YYM; Bruijstens AL; Barro C; Michalak Z; Melief MJ; Wierenga AF; van Pelt ED; Neuteboom RF; Kuhle J; Hintzen RQ
Neurology; 2019 Sep; 93(10):e968-e974. PubMed ID: 31383792
[TBL] [Abstract][Full Text] [Related]
6. High serum neurofilament levels are observed close to disease activity events in pediatric-onset MS and MOG antibody-associated diseases.
Ziaei A; Nasr Z; Hart J; Francisco C; Rutatangwa A; Leppert D; Kuhle J; Flanagan E; Waubant E
Mult Scler Relat Disord; 2023 Jun; 74():104704. PubMed ID: 37031551
[TBL] [Abstract][Full Text] [Related]
7. Serum neurofilament levels and patient-reported outcomes in multiple sclerosis.
Galetta K; Deshpande C; Healy BC; Glanz B; Ziehn M; Saxena S; Paul A; Saleh F; Collins M; Gaitan-Walsh P; Castro-Mendoza P; Weiner HL; Chitnis T
Ann Clin Transl Neurol; 2021 Mar; 8(3):631-638. PubMed ID: 33492760
[TBL] [Abstract][Full Text] [Related]
8. Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis.
Thebault S; Abdoli M; Fereshtehnejad SM; Tessier D; Tabard-Cossa V; Freedman MS
Sci Rep; 2020 Jun; 10(1):10381. PubMed ID: 32587320
[TBL] [Abstract][Full Text] [Related]
9. Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.
Monreal E; Fernández-Velasco JI; García-Sánchez MI; Sainz de la Maza S; Llufriu S; Álvarez-Lafuente R; Casanova B; Comabella M; Ramió-Torrentà L; Martínez-Rodríguez JE; Brieva L; Saiz A; Eichau S; Cabrera-Maqueda JM; Villarrubia N; Espiño M; Pérez-Miralles F; Montalbán X; Tintoré M; Quiroga-Varela A; Domínguez-Mozo MI; Rodríguez-Jorge F; Chico-García JL; Lourido D; Álvarez-Cermeño JC; Masjuan J; Costa-Frossard L; Villar LM
JAMA Neurol; 2023 Apr; 80(4):397-403. PubMed ID: 36848127
[TBL] [Abstract][Full Text] [Related]
10. Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD.
Watanabe M; Nakamura Y; Michalak Z; Isobe N; Barro C; Leppert D; Matsushita T; Hayashi F; Yamasaki R; Kuhle J; Kira JI
Neurology; 2019 Sep; 93(13):e1299-e1311. PubMed ID: 31471502
[TBL] [Abstract][Full Text] [Related]
11. Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.
Meier S; Willemse EAJ; Schaedelin S; Oechtering J; Lorscheider J; Melie-Garcia L; Cagol A; Barakovic M; Galbusera R; Subramaniam S; Barro C; Abdelhak A; Thebault S; Achtnichts L; Lalive P; Müller S; Pot C; Salmen A; Disanto G; Zecca C; D'Souza M; Orleth A; Khalil M; Buchmann A; Du Pasquier R; Yaldizli Ö; Derfuss T; Berger K; Hermesdorf M; Wiendl H; Piehl F; Battaglini M; Fischer U; Kappos L; Gobbi C; Granziera C; Bridel C; Leppert D; Maleska Maceski A; Benkert P; Kuhle J
JAMA Neurol; 2023 Mar; 80(3):287-297. PubMed ID: 36745446
[TBL] [Abstract][Full Text] [Related]
12. Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis.
Reinert MC; Benkert P; Wuerfel J; Michalak Z; Ruberte E; Barro C; Huppke P; Stark W; Kropshofer H; Tomic D; Leppert D; Kuhle J; Brück W; Gärtner J
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32404429
[TBL] [Abstract][Full Text] [Related]
13. NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study.
Uphaus T; Steffen F; Muthuraman M; Ripfel N; Fleischer V; Groppa S; Ruck T; Meuth SG; Pul R; Kleinschnitz C; Ellwardt E; Loos J; Engel S; Zipp F; Bittner S
EBioMedicine; 2021 Oct; 72():103590. PubMed ID: 34571362
[TBL] [Abstract][Full Text] [Related]
14. Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis.
Fox RJ; Cree BAC; de Sèze J; Gold R; Hartung HP; Jeffery D; Kappos L; Montalban X; Weinstock-Guttman B; Singh CM; Altincatal A; Belviso N; Avila RL; Ho PR; Su R; Engle R; Sangurdekar D; de Moor C; Fisher E; Kieseier BC; Rudick RA
Neurology; 2024 May; 102(9):e209357. PubMed ID: 38648580
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis.
McComb M; Krikheli M; Uher T; Browne RW; Srpova B; Oechtering J; Maceski AM; Tyblova M; Jakimovski D; Ramasamy DP; Bergsland N; Krasensky J; Noskova L; Fialova L; Weinstock-Guttman B; Havrdova EK; Vaneckova M; Zivadinov R; Horakova D; Kuhle J; Ramanathan M
J Clin Lipidol; 2020; 14(5):675-684.e2. PubMed ID: 32758395
[TBL] [Abstract][Full Text] [Related]
16. Association of intrathecal pleocytosis and IgG synthesis with axonal damage in early MS.
Engel S; Steffen F; Uphaus T; Scholz-Kreisel P; Zipp F; Bittner S; Luessi F
Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32019769
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum neurofilament light chain in children autism spectrum disorder: A case control study.
He WC; Zhang XJ; Zhang YQ; Zhang WJ
Neurotoxicology; 2020 Sep; 80():87-92. PubMed ID: 32592719
[TBL] [Abstract][Full Text] [Related]
18. Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years.
Cantó E; Barro C; Zhao C; Caillier SJ; Michalak Z; Bove R; Tomic D; Santaniello A; Häring DA; Hollenbach J; Henry RG; Cree BAC; Kappos L; Leppert D; Hauser SL; Benkert P; Oksenberg JR; Kuhle J
JAMA Neurol; 2019 Nov; 76(11):1359-1366. PubMed ID: 31403661
[TBL] [Abstract][Full Text] [Related]
19. Association of serum biomarker neurofilament light concentration with post-stroke depression: A preliminary study.
Zhao H; Mo M; Miao C; Li L; Yang H; Liu Y; Yang G
Gen Hosp Psychiatry; 2020; 64():17-25. PubMed ID: 32078857
[TBL] [Abstract][Full Text] [Related]
20. Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study.
Jakimovski D; Kuhle J; Ramanathan M; Barro C; Tomic D; Hagemeier J; Kropshofer H; Bergsland N; Leppert D; Dwyer MG; Michalak Z; Benedict RHB; Weinstock-Guttman B; Zivadinov R
Ann Clin Transl Neurol; 2019 Sep; 6(9):1757-1770. PubMed ID: 31437387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
